Cancer
Topoisomerase inhibitors (etoposide, irinotecan)
Drugs that trap DNA-cutting enzymes on DNA: etoposide (topoisomerase II) in testicular tumours and small cell lung cancer; irinotecan (topoisomerase I) in colorectal cancer.
آلية العمل
- Topoisomerases cut DNA to relieve the strain of unwinding and then reseal it.
- Etoposide stabilises the topoisomerase II–DNA complex, leaving double-strand breaks; it acts in S and G2 phases.
- Irinotecan (via its metabolite SN-38) and topotecan trap topoisomerase I, leaving single-strand breaks that become lethal at replication.
الأهداف الجزيئية
- Topoisomerase II: Poison (etoposide)
- Topoisomerase I: Poison (irinotecan, topotecan)
أدوية Topoisomerase inhibitors (etoposide, irinotecan)
Topoisomerase II inhibitor
- Etoposide (In BEP and EP regimens.)
Topoisomerase I inhibitors (camptothecins)
- Irinotecan (Prodrug; FOLFIRI.)
- Topotecan
الاستخدامات العلاجية
- Testicular germ cell tumours, including seminoma (etoposide with cisplatin)
- Small cell lung cancer (etoposide with a platinum drug)
- Metastatic colorectal cancer (irinotecan with a fluoropyrimidine)
الأمراض التي يعالجها
الآثار الجانبية
- Myelosuppression
- Severe diarrhoea, early (cholinergic) and late (irinotecan)
- Hair loss and mucositis
- Secondary leukaemia (etoposide)
موانع الاستعمال حسب الحالة
- Gilbert syndrome or low UGT1A1 activity (irinotecan) (بحذر): SN-38 is inactivated by UGT1A1: low activity causes severe neutropenia and diarrhoea.
- Ulcerative colitis (بحذر): Its diarrhoea can be severe.
- Pregnancy (ممنوع): Cytotoxic to the fetus.
مكتوب من
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 35, Anticancer Drugs, Topoisomerase inhibitors
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 54, Cancer Chemotherapy, Topoisomerase inhibitors
مرجع تعليمي، وليس استشارة طبية أو تشخيصاً أو علاجاً.